Skip to content
10-K

Annual Report

GENOCEA BIOSCIENCES, INC.

0001457612-22-000039

← back to feed
Filed
Mar 18, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Mar 15, 2022 58.73M sh
Shares Diluted FY 2021 · Dec 31, 2021 68.58M sh
Shares Diluted FY 2021 · Dec 31, 2020 46.55M sh
Capex FY 2021 · Dec 31, 2021 $3.29M
Capex FY 2021 · Dec 31, 2020 $2.59M
Operating Cash Flow FY 2021 · Dec 31, 2021 −$45.37M
Operating Cash Flow FY 2021 · Dec 31, 2020 −$41.65M
Long Term Debt FY 2021 · Dec 31, 2021 $4.15M
Long Term Debt FY 2021 · Dec 31, 2020 $0
Short Term Debt FY 2021 · Dec 31, 2021 $4.64M
Short Term Debt FY 2021 · Dec 31, 2020 $13.86M
Cash And Equivalents FY 2021 · Dec 31, 2021 $37.15M
Cash And Equivalents FY 2021 · Dec 31, 2020 $79.77M
Stockholders Equity FY 2021 · Dec 31, 2021 $27.08M
Stockholders Equity FY 2021 · Dec 31, 2020 $8.98M
Stockholders Equity FY 2021 · Dec 31, 2019 $25.04M
Current Liabilities FY 2021 · Dec 31, 2021 $18.68M
Current Liabilities FY 2021 · Dec 31, 2020 $25M
Total Liabilities FY 2021 · Dec 31, 2021 $28.89M
Total Liabilities FY 2021 · Dec 31, 2020 $89.51M
Current Assets FY 2021 · Dec 31, 2021 $41.82M
Current Assets FY 2021 · Dec 31, 2020 $82.23M
Total Assets FY 2021 · Dec 31, 2021 $55.97M
Total Assets FY 2021 · Dec 31, 2020 $98.49M
Eps Diluted FY 2021 · Dec 31, 2021 −$0.48
Eps Diluted FY 2021 · Dec 31, 2020 −$1.11
Eps Basic FY 2021 · Dec 31, 2021 −$0.48
Eps Basic FY 2021 · Dec 31, 2020 −$0.98
Sga Expense FY 2021 · Dec 31, 2021 $14.71M
Sga Expense FY 2021 · Dec 31, 2020 $14.39M
Rd Expense FY 2021 · Dec 31, 2021 $39.02M
Rd Expense FY 2021 · Dec 31, 2020 $33.96M
Net Income FY 2021 · Dec 31, 2021 −$33.2M
Net Income FY 2021 · Dec 31, 2020 −$43.71M
Operating Income FY 2021 · Dec 31, 2021 −$52.09M
Operating Income FY 2021 · Dec 31, 2020 −$46.99M